Hillsdale Investment Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-226,400
| Closed | -$4.6M | – | 581 |
|
|
2022
Q4 | $4.6M | Buy |
226,400
+1,000
| +0.4% | +$20.3K | 0.39% | 93 |
|
|
2022
Q3 | $5.78M | Sell |
225,400
-23,600
| -9% | -$605K | 0.52% | 46 |
|
|
2022
Q2 | $5.92M | Buy |
249,000
+1,400
| +0.6% | +$33.3K | 0.47% | 48 |
|
|
2022
Q1 | $5.58M | Buy |
+247,600
| New | +$5.58M | 0.36% | 88 |
|
|
2020
Q4 | – | Sell |
-185,400
| Closed | -$3.23M | – | 602 |
|
|
2020
Q3 | $3.23M | Hold |
185,400
| – | – | 0.32% | 95 |
|
|
2020
Q2 | $3.12M | Buy |
+185,400
| New | +$3.12M | 0.28% | 105 |
|
|
2018
Q2 | – | Sell |
-80,300
| Closed | -$1.32M | – | 503 |
|
|
2018
Q1 | $1.32M | Sell |
80,300
-10,000
| -11% | -$165K | 0.18% | 99 |
|
|
2017
Q4 | $1.63M | Hold |
90,300
| – | – | 0.26% | 58 |
|
|
2017
Q3 | $1.74M | Hold |
90,300
| – | – | 0.29% | 51 |
|
|
2017
Q2 | $1.07M | Sell |
90,300
-13,000
| -13% | -$153K | 0.21% | 93 |
|
|
2017
Q1 | $1.13M | Buy |
+103,300
| New | +$1.13M | 0.22% | 83 |
|